Release Date: 08/09/11 14:12 Summary: Response to ASX Price Query Price Sensitive: Yes Download Document 129.16KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%